Thrombolytic Therapy    Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Diabetes Mellitus the Declare-Diabetes Trial (a Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation in Diabetic Patients) J Am Coll Cardiol (2008) 51;1181-7 S. W. Lee, et al. Association of Impaired Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with Ventricular Tachycardia and Ventricular Fibrillation Following Fibrinolytic Therapy for St-Segment Elevation Myocardial Infarction J Am Coll Cardiol (2008) 51;546-51 C. M. Gibson, et al. Explaining Age-Specific Inequalities in Mortality from All Causes, Cardiovascular Disease and Ischaemic Heart Disease among South Korean Male Public Servants: Relative and Absolute Perspectives Heart (2008) 94;75-82 Y. H. Khang, et al. Physiological Evaluation of the Provisional Side-Branch Intervention Strategy for Bifurcation Lesions Using Fractional Flow Reserve Eur Heart J (2008) 29;726-732 B. K. Koo, et al. Clinical Characteristics and in-Hospital Outcomes of Patients with Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery: Insights from the Society of Thoracic Surgeons National Cardiac Database Circulation (2008) 117;876-85 R. H. Mehta, et al. Long-Term Clinical Outcomes after Sirolimus-Eluting Stent Implantation for Treatment of Restenosis within Bare-Metal Versus Drug-Eluting Stents Catheter Cardiovasc Interv (2008) 71;594-8 C. Whan Lee, et al. Late Target Lesion Revascularization after Implantation of Sirolimus-Eluting Stent Catheter Cardiovasc Interv (2008) 71;299-303 M. K. Hong, et al. A Three-Vessel Virtual Histology Intravascular Ultrasound Analysis of Frequency and Distribution of Thin-Cap Fibroatheromas in Patients with Acute Coronary Syndrome or Stable Angina Pectoris Am J Cardiol (2008) 101;568-72 M. K. Hong, et al. Rescue Angioplasty or Repeat Fibrinolysis after Failed Fibrinolytic Therapy for St-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trials J Am Coll Cardiol (2007) 49;422-30 H. C. Wijeysundera, et al. Efficacy and Safety of Triple Antiplatelet Therapy with and without Concomitant Anticoagulation During Elective Percutaneous Coronary Intervention (the Remove Trial) Am J Cardiol (2007) 100;1099-102 R. Valencia, et al. Frequency of Coronary Arterial Late Angiographic Stent Thrombosis (Last) in the First Six Months: Outcomes with Drug-Eluting Stents Versus Bare Metal Stents Am J Cardiol (2007) 99;774-8 D. W. Park, et al. Results and Predictors of Angiographic Restenosis and Long-Term Adverse Cardiac Events after Drug-Eluting Stent Implantation for Aorto-Ostial Coronary Artery Disease Am J Cardiol (2007) 99;760-5 D. W. Park, et al. Relationship of Treatment Delays and Mortality in Patients Undergoing Fibrinolysis and Primary Percutaneous Coronary Intervention. The Global Registry of Acute Coronary Events Heart (2007) 93;1552-5 B. Nallamothu, et al. Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for St-Elevation Myocardial Infarction Circulation (2007) 115;2822-8 J. L. Mega, et al. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents N Engl J Med (2007) 356;1020-9 L. Mauri, et al. St-Segment Deviation Analysis of the Admission 12-Lead Electrocardiogram as an Aid to Early Diagnosis of Acute Myocardial Infarction with a Cardiac Magnetic Resonance Imaging Gold Standard J Am Coll Cardiol (2007) 50;1021-8 T. N. Martin, et al. Comparison of Six-Month Angiographic and Three-Year Outcomes after Sirolimus-Eluting Stent Implantation Versus Brachytherapy for Bare Metal in-Stent Restenosis Am J Cardiol (2007) 100;425-30 S. W. Lee, et al. Comparison of Triple Versus Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation (from the Declare-Long Trial) Am J Cardiol (2007) 100;1103-8 S. W. Lee, et al. Frequency of Stent Fracture as a Cause of Coronary Restenosis after Sirolimus-Eluting Stent Implantation Am J Cardiol (2007) 100;627-30 S. H. Lee, et al. Sirolimus-Eluting Stent Implantation for Treatment of Proximal Left Anterior Descending Coronary Artery Lesions: Long-Term Outcome and Predictors of Adverse Cardiac Events Catheter Cardiovasc Interv (2007) 70;368-73 C. W. Lee, et al. Incidence and Predictors of Recurrent Restenosis Following Implantation of Drug-Eluting Stents for in-Stent Restenosis Catheter Cardiovasc Interv (2007) 69;104-8 C. W. Lee, et al. Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent Implantation Am J Cardiol (2007) 100;610-4 B. K. Lee, et al. Early Invasive Versus Conservative Treatment in Patients with Failed Fibrinolysis--No Late Survival Benefit: The Final Analysis of the Middlesbrough Early Revascularisation to Limit Infarction (Merlin) Randomized Trial Am Heart J (2007) 153;763-71 B. Kunadian, et al. Long-Term Safety of a Novel Antianginal Agent in Patients with Severe Chronic Stable Angina: The Ranolazine Open Label Experience (Role) J Am Coll Cardiol (2007) 49;1027-34 M. J. Koren, et al. Effect of Celecoxib on Restenosis after Coronary Angioplasty with a Taxus Stent (Corea-Taxus Trial): An Open-Label Randomised Controlled Study Lancet (2007) 370;567-74 B. K. Koo, et al. Comparison of Mortality Benefit of Immediate Thrombolytic Therapy Versus Delayed Primary Angioplasty for Acute Myocardial Infarction Am J Cardiol (2007) 99;1384-8 D. M. Kent, et al. Intracoronary Infusion of the Mobilized Peripheral Blood Stem Cell by G-Csf Is Better Than Mobilization Alone by G-Csf for Improvement of Cardiac Function and Remodeling: 2-Year Follow-up Results of the Myocardial Regeneration and Angiogenesis in Myocardial Infarction with G-Csf and Intra-Coronary Stem Cell Infusion (Magic Cell) 1 Trial Am Heart J (2007) 153;237 e1-8 H. J. Kang, et al. Comparison of Virtual Histology to Intravascular Ultrasound of Culprit Coronary Lesions in Acute Coronary Syndrome and Target Coronary Lesions in Stable Angina Pectoris Am J Cardiol (2007) 100;953-9 M. K. Hong, et al. New Distal Embolic Protection Device the Fibernet 3 Dimensional Filter: First Carotid Human Study Catheter Cardiovasc Interv (2007) 69;1026-35 M. Henry, et al. Effects of Balloon-Based Distal Protection During Primary Percutaneous Coronary Intervention on Early and Late Infarct Size and Left Ventricular Remodeling: A Pilot Study Using Serial Contrast-Enhanced Magnetic Resonance Imaging Am Heart J (2007) 153;665 e1-8 J. Y. Hahn, et al. The Capture Registry: Predictors of Outcomes in Carotid Artery Stenting with Embolic Protection for High Surgical Risk Patients in the Early Post-Approval Setting Catheter Cardiovasc Interv (2007) 70;1025-33 W. A. Gray, et al. Effects of Pretreatment with Clopidogrel on Nonemergent Percutaneous Coronary Intervention after Fibrinolytic Administration for St-Segment Elevation Myocardial Infarction: A Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (Clarity-Timi) 28 Study Am Heart J (2008) 155;133-9 C. M. Gibson, et al. Primary Angioplasty Vs. Early Routine Post-Fibrinolysis Angioplasty for Acute Myocardial Infarction with St-Segment Elevation: The Gracia-2 Non-Inferiority, Randomized, Controlled Trial Eur Heart J (2007) 28;949-60 F. Fernandez-Aviles, et al. Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis--the Cavent Study: Rationale and Design of a Multicenter, Randomized, Controlled, Clinical Trial (Nct00251771) Am Heart J (2007) 154;808-14 T. Enden, et al. Variations in the Use of Emergency Pci for the Treatment of Re-Infarction Following Intravenous Fibrinolytic Therapy: Impact on Outcomes in Hero-2 Eur Heart J (2007) 28;1418-24 J. J. Edmond, et al. Transfer with Gp Iib/Iiia Inhibitor Tirofiban for Primary Percutaneous Coronary Intervention Vs. On-Site Thrombolysis in Patients with St-Elevation Myocardial Infarction (Stemi): A Randomized Open-Label Study for Patients Admitted to Community Hospitals Eur Heart J (2007) 28;2438-48 S. Dobrzycki, et al. Comparison of Three-Year Clinical Outcome of Sirolimus- and Paclitaxel-Eluting Stents Versus Bare Metal Stents in Patients with St-Segment Elevation Myocardial Infarction (from the Research and T-Search Registries) Am J Cardiol (2007) 99;1027-32 J. Daemen, et al. The Danish Multicentre Randomized Study of Fibrinolytic Therapy Vs. Primary Angioplasty in Acute Myocardial Infarction (the Danami-2 Trial): Outcome after 3 Years Follow-Up Eur Heart J (2007) M. Busk, et al. Initial Aspirin Dose and Outcome among St-Elevation Myocardial Infarction Patients Treated with Fibrinolytic Therapy Circulation (2008) 117;192-9 J. S. Berger, et al. Outcomes and Complications Associated with Off-Label and Untested Use of Drug-Eluting Stents JAMA (2007) 297;1992-2000 N. Beohar, et al. Infarct Size, Ejection Fraction, and Mortality in Diabetic Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy Am Heart J (2007) 154;743-50 J. R. Alegria, et al.